Cathie's Ark Logo
undefined Logo

ARKG Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Date
Direction
Shares
Fund Weight
Fund
December 20, 2024
BUY30.076k0.037%ARKG
December 18, 2024
BUY24.522k0.0261%ARKG
December 16, 2024
BUY24.295k0.0293%ARKG
December 13, 2024
BUY7.067k0.0078%ARKG
November 19, 2024
BUY59.278k0.0726%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
0.04%
🏋🏿‍♂️Weight Rank In ARKG🌏Country
22🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds
176

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA